Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer: A Systematic Review with Meta-Analysis

BACKGROUND: This study aims to comprehensively summarize the currently available evidences on the efficacy and safety of gemcitabine plus erlotinib for treating advanced pancreatic cancer. METHODOLOGY/PRINCIPAL FINDINGS: PubMed, EMBASE, The Cochrane Library and abstracts of recent major conferences...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yang, Zu-Yao, Yuan, Jin-Qiu, Di, Meng-Yang, Zheng, Da-Yong, Chen, Jin-Zhang, Ding, Hong, Wu, Xin-Yin, Huang, Ya-Fang, Mao, Chen, Tang, Jin-Ling
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2013
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3589410/
https://ncbi.nlm.nih.gov/pubmed/23472089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0057528
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki